Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
Choosing between Dyne Therapeutics (DYN +5.87%) and Recursion Pharmaceuticals (RXRX +3.54%) requires balancing the potential of targeted muscle-tissue therapies against the broad, data-driven power of artificial intelligence in drug discovery. Dyne…
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
As the biotechnology landscape shifts toward personalized medicine and advanced computing, investors are weighing established leaders against emerging tech-driven disruptors. Moderna (MRNA +9.99%) and Recursion Pharmaceuticals (RXRX +3.54%) offer…
Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Nano Banana Pro prompted by THE DECODER Anthropic is launching its own drug development programs for neglected diseases that the traditional pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan says new AI models could cut…
Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are Saying
Viking Therapeutics (VKTX 0.11%) is one of the hopefuls in a very exciting pharmaceutical and biotech space right now: the weight loss drug market. Today, pharma giants Eli Lilly and Novo Nordisk dominate this area with their drugs, but demand is…
Brookfield Renewable: Simplification Catalyst May Favor Brookfield Renewable Partners
Brookfield Renewable Corporation is evaluating a merger with Brookfield Renewable Partners to create a single publicly traded entity. BEPC trades at a 7.7% premium to BEP despite identical economic exposure, payments, and platform access, largely…
What's powering India's stock market rally? Nifty and sensex post strong weekly gains | Dynamite News
Post Published By: Donika Singh Updated: 4 July 2026, 9:59 AM IST New Delhi: The Indian equity benchmarks posted a fourth consecutive week of gains, over sustained correction in crude oil prices and expectations of a more favourable global interest…
India's luxury homebuyer is changing, and so is the market
The face of India's luxury homebuyer is changing. For decades, the country's most expensive homes were the preserve of legacy business families and industrialists. Today, a different kind of buyer is walking into luxury sales offices —…
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
Biogen (BIIB +3.04%) built itself into a biotech giant thanks to its portfolio of multiple sclerosis (MS) drugs -- but in biotech and pharma, revenue growth depends on the life of a patent. Once a company loses exclusivity, generics or biosimilars…
3 Best Movies To Watch On Prime Video This Weekend (#1 Is Jason Statham's Bold Action Thriller)
Prime Video subscribers can watch a classic, an action thriller with a major star, and a recent release this weekend on the streaming service, and all three movies promise to leave viewers pleasantly surprised for different reasons. On last…
Mike Huckabee's False-Advertising-Related Case Against Meta Can Go Forward
From the June 23 decision in Huckabee v. Meta Platforms, Inc., by Third Circuit Judge Peter Phipps, joined by Judges Arianna Freeman and Emil Bove: Mike Huckabee … is a Baptist minister, the former Governor of Arkansas, a two-time…
302,995 Shares in Teva Pharmaceutical Industries Ltd. $TEVA Purchased by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd bought a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 302,995 shares of…
Smithbridge Asset Management Inc. DE Has $5.67 Million Holdings in Eli Lilly and Company $LLY
Smithbridge Asset Management Inc. DE trimmed its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 51.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The…
Root Financial Partners LLC Sells 1,304 Shares of Eli Lilly and Company $LLY
Root Financial Partners LLC reduced its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 44.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor…
Capital Asset Advisory Services LLC Lowers Holdings in Eli Lilly and Company $LLY
Capital Asset Advisory Services LLC cut its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 18.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned…
Rep. Gilbert Ray Cisneros, Jr. Acquires Shares of Eli Lilly and Company (NYSE:LLY)
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on July 02nd, the Representative disclosed that they had bought between $50,001 and $100,000 in Eli…
Receive a Daily briefing on Pharma Industry News
Get Started